Solventum Co. (NYSE:SOLV) Shares Acquired by Public Sector Pension Investment Board

Public Sector Pension Investment Board boosted its position in Solventum Co. (NYSE:SOLV) by 22.4% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,920 shares of the company’s stock after buying an additional 900 shares during the quarter. Public Sector Pension Investment Board’s holdings in Solventum were worth $343,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. Deseret Mutual Benefit Administrators acquired a new stake in Solventum in the second quarter valued at $25,000. Hollencrest Capital Management acquired a new stake in shares of Solventum in the 2nd quarter valued at about $25,000. Richard W. Paul & Associates LLC bought a new position in shares of Solventum during the second quarter worth about $26,000. Family Firm Inc. acquired a new position in Solventum in the second quarter worth about $26,000. Finally, Copeland Capital Management LLC bought a new stake in Solventum in the third quarter valued at about $26,000.

Solventum Stock Performance

Shares of NYSE:SOLV opened at $69.96 on Monday. The firm’s 50 day moving average is $70.69 and its two-hundred day moving average is $62.89. The company has a debt-to-equity ratio of 2.45, a quick ratio of 0.83 and a current ratio of 1.15. Solventum Co. has a 52 week low of $47.16 and a 52 week high of $96.05.

Wall Street Analyst Weigh In

Several research analysts have recently commented on SOLV shares. BTIG Research started coverage on Solventum in a research report on Thursday, September 5th. They issued a “neutral” rating for the company. Mizuho started coverage on shares of Solventum in a report on Wednesday, December 4th. They issued a “neutral” rating and a $70.00 price objective for the company. Wolfe Research initiated coverage on shares of Solventum in a report on Thursday, September 26th. They set a “peer perform” rating on the stock. The Goldman Sachs Group lifted their price target on shares of Solventum from $48.00 to $54.00 and gave the company a “sell” rating in a report on Monday, August 12th. Finally, Morgan Stanley increased their price objective on shares of Solventum from $60.00 to $73.00 and gave the stock an “equal weight” rating in a research note on Monday, November 11th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and one has issued a buy rating to the company. Based on data from MarketBeat.com, Solventum presently has an average rating of “Hold” and an average target price of $68.29.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.